Background Primary HPV testing (without the Pap test) has recently been recommended as
a cervical cancer screening option in the United States. US women's awareness and …

Background The human papillomavirus (HPV) test, administered alone without the
Papanicolaou (Pap) test, was recently recognized as a cervical cancer screening option in …

Background Major organizations recommend cytology screening (Pap test) every 3 years for
women aged 21–65; women aged 30 to 65 have the option of adding the HPV test (co-test) …

Background: Current clinical guidelines recommended primary human papillomavirus (HPV)
screening for cervical cancer testing. Previous studies reported patient-level barriers (eg …

Background: Cervical cancer screening has shifted toward human papillomavirus (HPV)-
based testing, but uptake of primary HPV screening in the United States is unknown and …

Human papillomavirus (HPV) testing for cervical screening increases diagnosis of precancer
and reduces the incidence of cervical cancer more than cytology alone. However, real‐world …

Objective To investigate the HPV testing recommendations of US physicians who perform
cervical cancer screening. Methods Data from the 2015 DocStyles survey of US health care …

Primary human papillomavirus (HPV) testing, in which a high-risk HPV test is administered
without cytology, was first included in 2018 US cervical cancer screening guidelines …

Objective To study participant's acceptability of and attitudes towards human papillomavirus
(HPV) testing compared with cytology for cervical cancer screening and what impact having …

In the coming decade, primary testing for human papillomavirus (HPV) will likely become the
standard of care for cervical cancer screening in both low-and high-resource settings. This …